EpiBiologics
EpiBiologics develops antibody-based targeted therapies against membrane and extracellular proteins that drive underlying disease biology. The company provides an EpiTAC platform that enables the development of targeted therapies that degrade disease-driving membrane and extracellular proteins in a wide range of disorders.
Domain
epibiologics.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$107.0M
Founded
2021
Tech Stack (13 technologies)
Frequently Asked Questions
What technologies does EpiBiologics use?+
EpiBiologics uses 13 technologies including Adobe Fonts, Google Analytics, Google Tag Manager.
What industry is EpiBiologics in?+
EpiBiologics operates in the Biotechnology industry.
Where is EpiBiologics based?+
EpiBiologics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026